SCHEMBL6416249

SCHEMBL6416249

COCCNC(=O)C1c2ccccc2C(=O)NC1c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.51
ALDH1A1 P00352 3/20 0.51
MAPT P10636 1/20 0.51
HTT P42858 1/20 0.51
TP53 P04637 1/20 0.50
MDM2 Q00987 1/20 0.50
MAPK1 P28482 1/20 0.46
TSHR P16473 1/20 0.43
NPSR1 Q6W5P4 3/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
CYP1A2 P05177 1/20 0.39
ALOX15 P16050 1/20 0.39
GLA P06280 1/20 0.38
CASP1 P29466 1/20 0.38
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6417317 0.86 MAPT (0.47) KDM4EALDH1A1MAPTHTTTP53
SCHEMBL671560 0.76 HSD17B10 (0.45) ALDH1A1HTTMDM2CYP1A2
SCHEMBL671561 0.76 HSD17B10 (0.45) ALDH1A1HTTMDM2CYP1A2
SCHEMBL671559 0.76 HSD17B10 (0.45) ALDH1A1HTTMDM2CYP1A2
SCHEMBL6418985 0.69 TACR1 (0.44) ALDH1A1NPC1
SCHEMBL6411600 0.68 TP53 (0.65) KDM4EALDH1A1MAPTHTTTP53
SCHEMBL13477442 0.68 BRS3 (0.58) KDM4EALDH1A1MAPTHTTNPSR1
Isophthalic Acid SCHEMBL27999411 0.68 KMT2A (0.42) KDM4EALDH1A1MAPTGAAL3MBTL1
SCHEMBL2099808 0.68 MDM2 (0.75) KDM4EALDH1A1MAPTHTTTP53
SCHEMBL29921815 0.68 MDM2 (0.75) KDM4EALDH1A1MAPTHTTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis AXYS PHARMACEUTICALS, INC. (US) 2005-06-09 US claimed
WO-2004004727-A1 3,4-DIHYDROISOQUINOLIN-1-ONE DERIVATIVES AS INDUCERS OF APOPTOSIS AXYS PHARMACEUTICALS, INC. (US) 2004-01-15 WO claimed
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis AXYS PHARMACEUTICALS, INC. (US) 2005-06-09 US disclosed
WO-2004004727-A1 3,4-DIHYDROISOQUINOLIN-1-ONE DERIVATIVES AS INDUCERS OF APOPTOSIS AXYS PHARMACEUTICALS, INC. (US) 2004-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis CASP3, BAX, BAD KDM4E 2355/4885ALDH1A1 1368/4885MAPT 3291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.